Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.14 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.7.1 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.2 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.112 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.10 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.102 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.124 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46.6 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.119.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.6 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.621.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.125 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.103.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.92 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.101 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used